Francis Medical announced today that it has completed an oversubscribed $80 million Series C equity financing.

Keck Medicine of USC is participating in a national, multisite clinical trial examining if a water vapor system that uses small, targeted amounts of steam to kill cancer cells is a safe and effective ...

Background: Androgen ablation is often used in addition to low-dose-rate brachytherapy in the treatment of prostate cancer, particularly for disease with adverse features. We report a single ...

A report into recurrent prostate cancer by ... to androgen ablation from initial responsiveness. Thus, the broader application of early microenvironment-targeting therapy will rely on the ...

Francis Medical, Inc., a privately-held medical device company developing an innovative and proprietary water vapor ablation therapy for the treatment of prostate, kidney and bladder cancer, today ...

With the publication of the long-term results of two randomized screening trials and updates to screening guidelines from many organizations, the past 2 years have been eventful in the field of ...

Table I displays demographic, disease and treatment ... at least 90% of the prostate received) were averaged for a random sample of 25 patients each in the androgen ablation and no-androgen ...

But in others, the cancer can be aggressive and deadly. Prostate cancer that's detected early has the best chance for successful treatment. One in eight men will get prostate cancer at some point ...

AngioDynamics has obtained an FDA green light for its NanoKnife prostate cancer ablation system ... function-preserving treatment for men with prostate tumors,” AngioDynamics’ president ...

Prostate cancer is the second leading cause of ... Ultrasound Fusion–Guided Nanoparticle-Directed Focal Therapy for Prostate Ablation, Journal of Urology (2024). DOI: 10.1097/JU.